|
WO2002034771A2
(en)
*
|
2000-10-27 |
2002-05-02 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
|
HRP20090058A2
(en)
|
2002-06-11 |
2009-04-30 |
Eli Lilly And Company |
Precursor Forms of Drugs for Amino Acids with Incentive Activity
|
|
US7109383B2
(en)
|
2002-09-27 |
2006-09-19 |
Central Glass Company, Limited |
Fluorine-containing allyl ether compounds, their copolymers, and resist compositions and anti-reflection film materials using such copolymers
|
|
ATE487690T1
(en)
*
|
2003-06-26 |
2010-11-15 |
Taisho Pharmaceutical Co Ltd |
2-AMINOBICYCLO 3.1.0 HEXANE-2,6-DICARBONIC ACID ESTER DERIVATIVE
|
|
JP5485492B2
(en)
*
|
2004-12-15 |
2014-05-07 |
大正製薬株式会社 |
Drugs for the prevention and treatment of depression
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
JP2009512711A
(en)
|
2005-10-21 |
2009-03-26 |
ブレインセルス，インコーポレイティド |
Regulation of neurogenesis by PDE inhibition
|
|
US20070112017A1
(en)
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
TWI417095B
(en)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
CA2651862A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
JP2010502722A
(en)
|
2006-09-08 |
2010-01-28 |
ブレインセルス，インコーポレイティド |
Combinations containing 4-acylaminopyridine derivatives
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
EP2203439B1
(en)
|
2007-09-14 |
2011-01-26 |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
|
|
AU2008297877C1
(en)
|
2007-09-14 |
2013-11-07 |
Addex Pharma S.A. |
1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
|
|
CN101848893B
(en)
|
2007-09-14 |
2012-06-06 |
奥梅-杨森制药有限公司 |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
|
CN101861316B
(en)
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of the MGLUR2 receptor
|
|
MX2011002042A
(en)
|
2008-09-02 |
2011-06-20 |
Ortho Mcneil Janssen Pharm |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors.
|
|
ES2466341T3
(en)
|
2008-10-16 |
2014-06-10 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
WO2010060589A1
(en)
|
2008-11-28 |
2010-06-03 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
JP5707390B2
(en)
|
2009-05-12 |
2015-04-30 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド |
1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
EP2430022B1
(en)
|
2009-05-12 |
2013-11-20 |
Janssen Pharmaceuticals, Inc. |
1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
|
TW201129700A
(en)
|
2009-11-18 |
2011-09-01 |
Taisho Pharmaceutical Co Ltd |
Method for producing optically active bicyclo [310] hexane derivative using oxygen
|
|
WO2011061935A1
(en)
|
2009-11-19 |
2011-05-26 |
大正製薬株式会社 |
Process for producing 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative and intermediate thereof
|
|
WO2012062750A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
JP5870111B2
(en)
|
2010-11-18 |
2016-02-24 |
イーライ リリー アンド カンパニー |
4-Substituted-3-benzyloxy-bicyclo [3.1.0] hexane compounds as mGluR2 / 3 antagonists
|
|
AR083845A1
(en)
|
2010-11-18 |
2013-03-27 |
Lilly Co Eli |
3-PHENYLSULPHANYLME-BICYCLE COMPOUNDS [3.1.0] HEXANE 4-REPLACED AS ANTAGONISTS OF mGluR2 / 3
|
|
HRP20160676T1
(en)
|
2011-06-17 |
2016-07-15 |
Eli Lilly And Company |
DERIVATIVE BICYCLES [3.1.0] HEXAN-2,6-DICARBOXYLIC ACIDS AS MGLU2 RECEPTOR AGONISTS
|
|
WO2013062680A1
(en)
*
|
2011-10-25 |
2013-05-02 |
Braincells, Inc. |
Novel compounds and compositions thereof for treating nervous system disorders
|
|
RU2496495C2
(en)
*
|
2011-12-05 |
2013-10-27 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт нормальной физиологии имени П.К. Анохина РАМН |
USING SELECTIVE ANTAGONIST OF GLUAMATE RECEPTOR Ro-256981 FOR TARGETED EFFECT ON COGNITIVE FUNCTIONS
|
|
MY169069A
(en)
*
|
2012-06-01 |
2019-02-12 |
Taisho Pharmaceutical Co Ltd |
Prodrug of fluorine-containing amino acid
|
|
JO3368B1
(en)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
6, 7- dihydropyrazolu [5,1-a] pyrazine-4 (5 hands) -on compounds and their use as negative excretory regulators of Miglore 2 receptors.
|
|
JO3367B1
(en)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
ME03518B
(en)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
COMBINATIONS INCLUDING POSITIVE ALOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR APPLICATIONS
|
|
AU2015208233B2
(en)
|
2014-01-21 |
2019-08-29 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
AU2017254266B2
(en)
|
2016-04-18 |
2021-03-11 |
Taisho Pharmaceutical Co., Ltd. |
Prodrug of amino acid derivative
|
|
JP7314494B2
(en)
*
|
2017-10-17 |
2023-07-26 |
大正製薬株式会社 |
Pharmaceuticals containing prodrugs of amino acid derivatives
|
|
JP2024004505A
(en)
*
|
2020-11-26 |
2024-01-17 |
大正製薬株式会社 |
Method for producing amino acid derivatives
|